Here’s what you should know:
1. Boston Scientific’s sales increased 5.6 percent year-over-year on a reported basis. .
2. Boston Scientific reported adjusted earnings of $283 million or $0.20 per share.
3. Boston Scientific CEO Mike Mahoney said in a release, “Our global team is delivering strong performance as we continue to invest in a deep and innovative portfolio and expand into faster-growing markets.”
4. Boston Scientific’s endoscopy division increased its sales by $7 million year-over-year.
5. Concerning rest-of-year outlooks, Boston Scientific expects earnings between $8.98 billion and $9.01 billion or a growth of up to 8 percent.
More articles on gastroenterology:
Gastro Health adds Dr. Robert Kaplan — 4 insights
GI center to know: Concord Endoscopy
CapsoVision earns CE Mark for CapsoCam Plus — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
